"Tissue Engineering" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Generating tissue in vitro for clinical applications, such as replacing wounded tissues or impaired organs. The use of TISSUE SCAFFOLDING enables the generation of complex multi-layered tissues and tissue structures.
| Descriptor ID |
D023822
|
| MeSH Number(s) |
E05.481.500.311.500 J01.293.069.249.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Tissue Engineering".
Below are MeSH descriptors whose meaning is more specific than "Tissue Engineering".
This graph shows the total number of publications written about "Tissue Engineering" by people in this website by year, and whether "Tissue Engineering" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tissue Engineering" by people in Profiles.
-
In Vitro and In Vivo Preclinical Testing of Pericyte-Engineered Grafts for the Correction of Congenital Heart Defects. J Am Heart Assoc. 2020 02 18; 9(4):e014214.
-
Regulation of proteoglycan production by varying glucose concentrations controls fiber formation in tissue engineered menisci. Acta Biomater. 2019 12; 100:173-183.
-
Reconstruction of the pulmonary artery by a novel biodegradable conduit engineered with perinatal stem cell-derived vascular smooth muscle cells enables physiological vascular growth in a large animal model of congenital heart disease. Biomaterials. 2019 10; 217:119284.
-
Multicenter Experience With 500 CardioCel Implants Used for the Repair of Congenital Heart Defects. Ann Thorac Surg. 2019 12; 108(6):1883-1888.
-
Amnion-Based Scaffold with Enhanced Strength and Biocompatibility for In Vivo Vascular Repair. Tissue Eng Part A. 2019 04; 25(7-8):603-619.
-
Tissue Engineered Bone Differentiated From Human Adipose Derived Stem Cells Inhibit Posterolateral Fusion in an Athymic Rat Model. Spine (Phila Pa 1976). 2018 04 15; 43(8):533-541.
-
Tissue engineering a human phalanx. J Tissue Eng Regen Med. 2017 08; 11(8):2373-2387.
-
Expansion and characterization of neonatal cardiac pericytes provides a novel cellular option for tissue engineering in congenital heart disease. J Am Heart Assoc. 2015 Jun 16; 4(6):e002043.
-
MicroRNAs in vascular tissue engineering and post-ischemic neovascularization. Adv Drug Deliv Rev. 2015 Jul 01; 88:78-91.
-
Growth factor delivery through self-assembling peptide scaffolds. Clin Orthop Relat Res. 2011 Oct; 469(10):2716-24.